Baxter International Inc. (BAX)
NYSE: BAX · Real-Time Price · USD
22.51
-0.24 (-1.05%)
At close: Oct 9, 2025, 4:00 PM EDT
22.84
+0.33 (1.47%)
After-hours: Oct 9, 2025, 7:50 PM EDT
Baxter International Revenue
Baxter International had revenue of $2.81B in the quarter ending June 30, 2025, with 4.31% growth. This brings the company's revenue in the last twelve months to $10.89B, up 3.60% year-over-year. In the year 2024, Baxter International had annual revenue of $10.64B with 2.66% growth.
Revenue (ttm)
$10.89B
Revenue Growth
+3.60%
P/S Ratio
1.06
Revenue / Employee
$286,500
Employees
38,000
Market Cap
11.56B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 10.64B | 276.00M | 2.66% |
Dec 31, 2023 | 10.36B | 303.00M | 3.01% |
Dec 31, 2022 | 10.06B | -2.09B | -17.20% |
Dec 31, 2021 | 12.15B | 473.00M | 4.05% |
Dec 31, 2020 | 11.67B | 311.00M | 2.74% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
BAX News
- 13 days ago - Baxter is First Manufacturer to Achieve Gold Resiliency Badge for IV Solutions, Nutrition Solutions and Premix Drugs from Healthcare Industry Resilience Collaborative (HIRC) - Business Wire
- 23 days ago - Baxter Launches Welch Allyn Connex 360 Vital Signs Monitor to Advance Connected Patient Monitoring - Business Wire
- 6 weeks ago - Is Now The Time To Buy Baxter Stock? - Forbes
- 2 months ago - Hospital Product Maker Baxter Stock Plunges On Trimmed Annual Outlook - Benzinga
- 2 months ago - Baxter International Inc. (BAX) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Baxter cuts forecast, misses estimates amid lingering hurricane impact on medical products unit - Reuters
- 2 months ago - Baxter Reports Second-Quarter 2025 Results - Business Wire
- 2 months ago - Vizient Reserve Program Expands Supply Assurance to Include IV Fluids in Collaboration With Baxter - Business Wire